购物车

全部删除
您的购物车当前为空

Siglec-15 Protein, Human, Recombinant (hFc)

产品编号 TMPS-00127

Siglec-15 Protein, Human, Recombinant (hFc) is expressed in HEK293 Cells. The accession number is Q6ZMC9.

Siglec-15 Protein, Human, Recombinant (hFc)

产品编号 TMPS-00127

Siglec-15 Protein, Human, Recombinant (hFc) is expressed in HEK293 Cells. The accession number is Q6ZMC9.

规格	价格	库存
50 μg	¥ 2,280	5日内发货
100 μg	¥ 3,160	5日内发货
1 mg	¥ 21,600	5日内发货

大包装 & 定制

加入购物车

TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。

实验操作小课堂

常见问题解答

资源下载

重组蛋白用户指南

产品信息

生物活性	Immobilized Anti-Siglec15 at 1.0 μg/ml (100 μl/well) can bind Siglec-15, hFc, Human with a EC 50 = 5.184 ng/ml and a linear range of 0.064−200.0 ng/ml when detected by Mouse Anti–Human IgG Fc-HRP.
产品描述	Siglec-15 Protein, Human, Recombinant (hFc) is expressed in HEK293 Cells. The accession number is Q6ZMC9.
种属	Human
表达系统	HEK293 Cells
标签	hFc
蛋白编号	Q6ZMC9
别名	SIGLEC-15,HsT1361,CD33L3
蛋白构建	Phe20-Thr263
蛋白纯度	> 90% as determined by SDS-PAGE
分子量	~54.3 kDa (Reducing conditions)
内毒素	< 1 EU/μg of protein as determined by the LAL method.
缓冲液	Lyophilized from a 0.2 μm filtered solution in PBS.
复溶方法	Reconstitute the lyophilized protein in sterile deionized water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing.
存储	Upon receiving, this product remains stable for up to 6 months at lower than -70°C. Upon reconstitution, the product should be stable for up to 1 week at 4°C or up to 3 months at -20°C. For long term storage it is recommended that a carrier protein (example 0.1% BSA) be added. Avoid repeated freeze-thaw cycles.
运输方式	In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.
研究背景	Siglec-15 preferentially recognizes the Neu5Acalpha2-6GalNAcalpha- structure. Siglec-15 associates with the activating adaptor proteins DNAX activation protein (DAP)12 and DAP10 via its lysine residue in the transmembrane domain. Siglec-15 is the second human Siglec identified to have an activating signaling potential; unlike Siglec-14, however, it does not have an inhibitory counterpart.